Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Immunohistochemistry-Paraffin: BAFFR/TNFRSF13C Antibody (BAFFR/1557) [NBP3-07543] - Formalin-fixed, paraffin-embedded human Tonsil stained with BAFFR/TNFRSF13C Mouse Monoclonal Antibody (BAFFR/1557).](http://images.novusbio.com/fullsize/BAFFR-TNFRSF13C-Antibody-BAFFR-1557-Immunohistochemistry-Paraffin-NBP3-07543-img0001.jpg "Immunohistochemistry-Paraffin: BAFFR/TNFRSF13C Antibody (BAFFR/1557) [NBP3-07543] - Formalin-fixed, paraffin-embedded human Tonsil stained with BAFFR/TNFRSF13C Mouse Monoclonal Antibody (BAFFR/1557).")
![Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody (C40/9225R) [NBP3-23606] - Formalin-fixed, paraffin-embedded human tonsil stained with CD40/TNFRSF5 Antibody (C40/9225R). Inset: PBS instead of primary antibody; secondary only negative control.](http://images.novusbio.com/fullsize/nbp3-23606_rabbit-cd40-tnfrsf5-mab-c40-9225r-2412025874810.jpg "Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody (C40/9225R) [NBP3-23606] - Formalin-fixed, paraffin-embedded human tonsil stained with CD40/TNFRSF5 Antibody (C40/9225R). Inset: PBS instead of primary antibody; secondary only negative control.")
![ELISA: IL-4 ELISA Development Kit [NBP3-11748] - Standard curve reference](http://images.novusbio.com/fullsize/IL-4-ELISA-Development-Kit-ELISA-NBP3-11748-img0001.jpg "ELISA: IL-4 ELISA Development Kit [NBP3-11748] - Standard curve reference")
![Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.](http://images.novusbio.com/fullsize/IL-21-Antibody-MT216G-21-3m-Neutralization-NBP3-18290-img0001.jpg "Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.")
![Western Blot: AICDA Peptide [NBP1-77235PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C](http://images.novusbio.com/fullsize/AICDA-Peptide-Western-Blot-NBP1-77235PEP-img0001.jpg "Western Blot: AICDA Peptide [NBP1-77235PEP] - blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C")
![Western Blot: CD81 Peptide [NBP1-77039PEP] - CD81 Peptide blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C.](http://images.novusbio.com/fullsize/CD81-Peptide-Western-Blot-NBP1-77039PEP-img0002.jpg "Western Blot: CD81 Peptide [NBP1-77039PEP] - CD81 Peptide blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C.")
![Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Validation in Human HL-60 Cell Lysate. Loading: 15 ug of lysates per lane.Antibodies: IL-21 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.](http://images.novusbio.com/fullsize/nbp1-76740pep_il-21-antibody-blocking-peptide-2711202419251583.jpg "Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Validation in Human HL-60 Cell Lysate. Loading: 15 ug of lysates per lane.Antibodies: IL-21 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.")
![SDS-Page: Recombinant Human CD81 Protein [NBP2-60215] - 15 % SDS-PAGE (3ug)](http://images.novusbio.com/fullsize/Recombinant-Human-CD81-Protein-SDS-Page-NBP2-60215-img0001.jpg "SDS-Page: Recombinant Human CD81 Protein [NBP2-60215] - 15 % SDS-PAGE (3ug)")
![SDS-Page: Recombinant Human AICDA Protein [NBP2-22671]](http://images.novusbio.com/fullsize/Recombinant-Human-AICDA-Protein-SDS-Page-NBP2-22671-img0002.jpg "SDS-Page: Recombinant Human AICDA Protein [NBP2-22671]")
![ELISA: Human CD81 ELISA Kit (Colorimetric) [NBP3-18222] - Standard Curve Reference](http://images.novusbio.com/fullsize/Human-CD81-ELISA-Kit-Colorimetric-ELISA-NBP3-18222-img0001.jpg "ELISA: Human CD81 ELISA Kit (Colorimetric) [NBP3-18222] - Standard Curve Reference")